ILIAS Biologics ILIAS Therapeutics

(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

ILIAS organizing Scientific Advisory Board(SAB) for Exosome Based Therapeutics Development

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 19-09-20 15:02
  • 조회 : 246회

본문


11 Sep 2019


ILIAS Biologics Inc. holding 'Exosome in Medicine' symposium with 10 Scientific Advisory Board members.


ILIAS Biologics has formed a Scientific Advisory Board(SAB) consisting of 10 global key opinion leaders for the exosome based therapeutics development. The SAB included Dr. Sai Kiang Lim(A*STAR), Dr. Ramkumar Menon(UTMB), Dr. You Han Bae(Univ. of Utah), Dr. In-San Kim(KIST) and other scholars and clinical experts in drug development, drug delivery and exosomes.


Press Link (Korean) : http://m.biospectator.com/view/news_view.php?varAtcId=8461 

 

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기